Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?
Karl Z Lukic, Allan L Coates
https://pubmed.ncbi.nlm.nih.gov/26079395/Actively Recruiting
Led by Gelb, Arthur F., M.D. · Updated on 2023-10-26
100
Participants Needed
2
Research Sites
30 weeks
Total Duration
This research aims to identify hidden small airways obstruction in children and adults with cystic fibrosis who have normal results on routine pre-bronchodilator lung function tests. It focuses on patients with both heterozygous and homozygous cystic fibrosis and explores the presence of lung issues not detected by usual spirometry measures like FEV1, FVC, and their ratios. The study builds on previous findings that small airways obstruction and emphysema can exist despite normal routine lung function tests. Participants undergo diagnostic tests including spirometry and lung CT scans to detect abnormal expiratory airflow at low lung volumes, which may indicate small airways obstruction or peripheral airway bronchiectasis. The study is retrospective and observational, assessing maximal expiratory flow volume loops at 75% and 80% expired lung volume to find airway limitations that routine tests might miss. During the study, researchers analyze existing lung function data and imaging results to measure small airway obstruction in cystic fibrosis patients. The main outcome is the detection of unsuspected small airway obstruction over a 5-year period. Participants routine spirometry results are reviewed alongside specialized measurements to better understand lung function in this population, helping to inform future diagnosis and management strategies.
CONDITIONS
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
A
Arthur F Gelb, MD
V
Vicki Masson, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gelb, Arthur F., M.D.
Lead Sponsor
Miller Children's & Women's Hospital Long Beach
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo spirometry and lung CT to detect unsuspected small airways obstruction despite normal routine lung function.
1 visit (in-person)
Duration - 5 years
Participants are monitored over 5 years to observe the presence of small airway obstruction and related lung changes.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Karl Z Lukic, Allan L Coates
https://pubmed.ncbi.nlm.nih.gov/26079395/A F Gelb, N Zamel
https://pubmed.ncbi.nlm.nih.gov/4684043/Vicki K Masson, Eliezer Nussbaum, Arthur F Gelb...
https://pubmed.ncbi.nlm.nih.gov/36914809/James C Hogg, Peter D Paré, Tillie-Louise Hackett
https://pubmed.ncbi.nlm.nih.gov/28151425/J Mead
https://pubmed.ncbi.nlm.nih.gov/5442364/A F Gelb, W M Gold, R R Wright...
https://pubmed.ncbi.nlm.nih.gov/4683321/Gelb, Arthur F., M.D.
Lead Sponsor
Miller Children's & Women's Hospital Long Beach
Collaborating Sponsor